109 related articles for article (PubMed ID: 35726806)
1. Validity of claims data for identifying cancer incidence in the Japan public health center-based prospective study for the next generation.
Ihira H; Goto A; Yamagishi K; Iso H; Iwasaki M; Sawada N; Tsugane S;
Pharmacoepidemiol Drug Saf; 2022 Sep; 31(9):972-982. PubMed ID: 35726806
[TBL] [Abstract][Full Text] [Related]
2. The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data.
Czwikla J; Jobski K; Schink T
BMC Med Res Methodol; 2017 Aug; 17(1):122. PubMed ID: 28806932
[TBL] [Abstract][Full Text] [Related]
3. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
4. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
5. The accuracy of Japanese claims data in identifying breast cancer cases.
Sato I; Yagata H; Ohashi Y
Biol Pharm Bull; 2015; 38(1):53-7. PubMed ID: 25744458
[TBL] [Abstract][Full Text] [Related]
6. The identification of incident cancers in UK primary care databases: a systematic review.
Rañopa M; Douglas I; van Staa T; Smeeth L; Klungel O; Reynolds R; Bhaskaran K
Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):11-8. PubMed ID: 25421570
[TBL] [Abstract][Full Text] [Related]
7. Cancer in Canada: Stage at diagnosis.
Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
[TBL] [Abstract][Full Text] [Related]
8. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
9. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
10. Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol.
Abraha I; Serraino D; Giovannini G; Stracci F; Casucci P; Alessandrini G; Bidoli E; Chiari R; Cirocchi R; De Giorgi M; Franchini D; Vitale MF; Fusco M; Montedori A
BMJ Open; 2016 Mar; 6(3):e010547. PubMed ID: 27016247
[TBL] [Abstract][Full Text] [Related]
11. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
12. Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.
de Luise C; Sugiyama N; Morishima T; Higuchi T; Katayama K; Nakamura S; Chen H; Nonnenmacher E; Hase R; Jinno S; Kinjo M; Suzuki D; Tanaka Y; Setoguchi S
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1153-1161. PubMed ID: 33960542
[TBL] [Abstract][Full Text] [Related]
13. Novel Algorithm for the Estimation of Cancer Incidence Using Claims Data in Japan: A Feasibility Study.
Ogawa T; Takahashi H; Saito H; Sagawa M; Aoki D; Matsuda K; Nakayama T; Kasahara Y; Kato K; Saitoh E; Morisada T; Saika K; Sawada N; Matsumura Y; Sobue T
JCO Glob Oncol; 2023 Jan; 9():e2200222. PubMed ID: 36749909
[TBL] [Abstract][Full Text] [Related]
14. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
15. [Cancer incidence in Japan].
Tsukuma H; Ajiki W; Oshima A
Gan To Kagaku Ryoho; 2004 Jun; 31(6):840-6. PubMed ID: 15222098
[TBL] [Abstract][Full Text] [Related]
16. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
17. Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study.
Lakoski SG; Willis BL; Barlow CE; Leonard D; Gao A; Radford NB; Farrell SW; Douglas PS; Berry JD; DeFina LF; Jones LW
JAMA Oncol; 2015 May; 1(2):231-7. PubMed ID: 26181028
[TBL] [Abstract][Full Text] [Related]
18. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
Ram P; Tiu A; Lo KB; Parikh K; Shah M
Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
[TBL] [Abstract][Full Text] [Related]
19. Infective endocarditis and cancer in the elderly.
García-Albéniz X; Hsu J; Lipsitch M; Logan RW; Hernández-Díaz S; Hernán MA
Eur J Epidemiol; 2016 Jan; 31(1):41-9. PubMed ID: 26683995
[TBL] [Abstract][Full Text] [Related]
20. Socio-economic inequalities in the incidence of four common cancers: a population-based registry study.
Tweed EJ; Allardice GM; McLoone P; Morrison DS
Public Health; 2018 Jan; 154():1-10. PubMed ID: 29128730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
